Judd W. Moul, MD, FACS, provides insight on screening and diagnosis of prostate cancer, and comments on the use of biomarker tests to aid in risk stratification, management, and treatment.
EP. 1: Introduction: A 64-Year-Old Man with Elevated PSA Levels
Judd W. Moul, MD, FACS, introduces the patient profile and discusses typical characteristics of patients undergoing prostate cancer screening in his practice.
EP. 2: Trends in Prostate Cancer Incidence and Severity
A commentary on increasing trends in prostate cancer incidence and how many patients typically present with severe disease.
EP. 3: Early Detection of Prostate Cancer: Challenges and Strategies
Judd W. Moul, MD, FACS, reviews challenges of early detection of prostate cancer, and strategies to mitigate them.
EP. 4: Modalities for Prostate Cancer Diagnosis, Grading, and Staging
A focused discussion on the use of tools such as digital rectal exam, prostate biopsy, and MRI in prostate cancer diagnosis, staging, and grading.
EP. 5: Pre-Biopsy Biomarker Tests for Prostate Cancer Risk Assessment
Judd W. Moul, MD, FACS, introduces available blood- and urine-based biomarker tests for prostate cancer screening, and discusses how they might overcome limitations of commonly used modalities.
EP. 6: Utilization and Timing of Biomarker Tests for Prostate Cancer
Judd W. Moul, MD, FACS, provides insight into the timing of biomarker testing in the prostate cancer screening process, and discusses which patients might benefit the most from testing.
EP. 7: Clinical Validity and Utility of an Exosome-Based Urine Biomarker Test
An overview of the clinical validity and utility of a urine-based, exosomal molecular test for prostate cancer screening and risk assessment.
EP. 8: Real-World Use of an Exosome-Based Urine Biomarker Test
Judd W. Moul, MD, FACS, gives a real-world overview of how the exosome-based test is used in clinical practice.
EP. 9: Recommended Management of the Profiled Patient
An expert urologic oncologist revisits a patient profile and discusses how he would have approached the patient’s prostate cancer screening process.
EP. 10: Remaining Unmet Needs and Future Directions in Prostate Cancer Screening
Judd W. Moul, MD, FACS, wraps up by discussing remaining unmet needs and potential future improvements in imaging modalities for prostate cancer screening.
2 Clarke Drive Cranbury, NJ 08512